Drugs / MSCs-Exo
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04313647 | Mar → Apr 2020 | — | Ruijin Hospital | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MSCs-Exo | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04313647 ↗ |
| Known as | MSC-EVs | “Mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) turn out to be a promising source of cell-free therapy.” PMID 34429860 ↗ Aug 2021 |
| Modality | Other / unclassified | “Mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs)” PMID 34429860 ↗ Aug 2021 |
| Route | Inhaled | “aerosol inhalation of MSCs-derived exosomes” NCT04313647 ↗ |